These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12224374)

  • 1. Antihypertensive medications and renal disease.
    Andrews L; Gibbs MA
    Nephrol Nurs J; 2002 Aug; 29(4):379-82. PubMed ID: 12224374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current options for the treatment of resistant hypertension.
    Ahmed MI; Pisoni R; Calhoun DA
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1385-93. PubMed ID: 19900021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in children with chronic renal failure.
    Lilova M
    Turk J Pediatr; 2005; 47 Suppl():28-31. PubMed ID: 15884664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The internist's role in treating hypertension in hemodialysis patients.
    Hirsch S
    QJM; 2009 Jul; 102(7):501-7. PubMed ID: 19383610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent update in the management of hypertension.
    Lim S
    Acta Med Indones; 2007; 39(4):186-91. PubMed ID: 18380058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension in patients with chronic renal disease].
    Laville M
    Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hypertension: the role of individualized therapy.
    Blake GH
    Am Fam Physician; 1994 Jul; 50(1):138-46, 149-50. PubMed ID: 8017249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension is harmful to dialysis patients and should be controlled.
    Foley RN; Agarwal R
    Semin Dial; 2007; 20(6):518-22. PubMed ID: 17991197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hypertension in chronic kidney disease: the Italian multicentric study.
    De Nicola L; Minutolo R; Gallo C; Zoccali C; Cianciaruso B; Conte M; Lupo A; Fuiano G; Gallucci M; Bonomini M; Chiodini P; Signoriello G; Bellizzi V; Mallamaci F; Nappi F; Conte G
    J Nephrol; 2005; 18(4):397-404. PubMed ID: 16245243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.